No Data
No Data
Why Pharvaris (PHVS) Is Advancing Today
JMP Securities Maintains Market Outperform on Pharvaris, Raises Price Target to $55
Pharvaris Analyst Ratings
JMP Securities Maintains Pharvaris(PHVS.US) With Buy Rating, Raises Target Price to $55
Analysts Offer Insights on Healthcare Companies: Stevanato Group (STVN), Galapagos (GLPG) and Pharvaris (PHVS)
Express News | Pharvaris NV : Leerink Partners Cuts Target Price to $28 From $30